172 related articles for article (PubMed ID: 32971496)
1. Simultaneous measurement of acalabrutinib, ibrutinib, and their metabolites in beagle dog plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Jiang Z; Shi L; Zhang Y; Lin G; Wang Y
J Pharm Biomed Anal; 2020 Nov; 191():113613. PubMed ID: 32971496
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel and quick UPLC-MS/MS method for the pharmacokinetic analysis of duvelisib in beagle dogs.
Shao Y; Xie S; Zhu H; Du X; Xu RA
J Pharm Biomed Anal; 2020 Aug; 187():113355. PubMed ID: 32442869
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification and pharmacokinetic investigation of selexipag and its main metabolite ACT-333679 in rat plasma by UPLC-MS/MS method.
Xie S; Shi L; Chen J; Xu RA; Ye X
J Pharm Biomed Anal; 2020 Oct; 190():113496. PubMed ID: 32768890
[TBL] [Abstract][Full Text] [Related]
4. Determination of Tropifexor in Beagle Dog Plasma by UPLC-MS/MS and Its Application in Pharmacokinetics.
Su YD; Wei XY; Su XH; Woshur G; Geng XN; Qiu XJ
J Anal Methods Chem; 2022; 2022():2823214. PubMed ID: 36164482
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
Veeraraghavan S; Viswanadha S; Thappali S; Govindarajulu B; Vakkalanka S; Rangasamy M
J Pharm Biomed Anal; 2015 Mar; 107():151-8. PubMed ID: 25594893
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of harmine, harmaline and their metabolites harmol and harmalol in beagle dog plasma by UPLC-ESI-MS/MS and its application to a pharmacokinetic study.
Zhang L; Teng L; Gong C; Liu W; Cheng X; Gu S; Deng Z; Wang Z; Wang C
J Pharm Biomed Anal; 2013 Nov; 85():162-8. PubMed ID: 23948761
[TBL] [Abstract][Full Text] [Related]
7. A rapid and sensitive UPLC-MS/MS method for the determination of zanubrutinib in beagle plasma and its application in pharmacokinetics.
Zhu YL; Ding HZ; Gou KF; Sun B; Chen Y; Zhang HW
Biomed Chromatogr; 2023 Jan; 37(1):e5504. PubMed ID: 36094354
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous Determination and Pharmacokinetics of Peimine and Peiminine in Beagle Dog Plasma by UPLC-MS/MS after the Oral Administration of
Wang Z; Cao F; Chen Y; Tang Z; Wang Z
Molecules; 2018 Jun; 23(7):. PubMed ID: 29958456
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Determination of Aesculin, Aesculetin, Fraxetin, Fraxin and Polydatin in Beagle Dog Plasma by UPLC-ESI-MS/MS and Its Application in a Pharmacokinetic Study after Oral Administration Extracts of
Wang Z; Zhu W; Liu H; Wu G; Song M; Yang B; Yang D; Wang Q; Kuang H
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205426
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of Guanfu base G and its active metabolites by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
Zhang L; Wang A; Wang X; Zhang Y; Li X; Liu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():1-6. PubMed ID: 24636893
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-tandem mass spectrometric method for the quantification of eliglustat in rat plasma and the application in a pre-clinical study.
Chen J; Shao Y; Zhu H; Chen X; Ye X
J Pharm Biomed Anal; 2020 Jan; 177():112858. PubMed ID: 31518862
[TBL] [Abstract][Full Text] [Related]
12. Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study.
Wang MJ; Zhao YH; Fan C; Wang YJ; Wang XQ; Qiu XJ; Shen RL
Drug Des Devel Ther; 2021; 15():4167-4175. PubMed ID: 34629864
[TBL] [Abstract][Full Text] [Related]
13. A simple method for the determination of Bosutinib in rat plasma by UPLC-MS/MS.
Xu Y; Huang XC; Dai S; Xiao Y; Zhou MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1004():93-7. PubMed ID: 26454795
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of four bioactive flavonoids from Polygonum orientale L. in dog plasma by UPLC-ESI-MS/MS and application of the technique to pharmacokinetic studies.
Huang Y; Zhang P; He F; Zheng L; Wang YL; Wu JZ
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():96-104. PubMed ID: 24662144
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid.
Beauvais D; Goossens JF; Boyle E; Allal B; Lafont T; Chatelut E; Herbaux C; Morschhauser F; Genay S; Odou P; Danel C
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():158-166. PubMed ID: 30029202
[TBL] [Abstract][Full Text] [Related]
16. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS.
Qiu X; Lin Q; Ning Z; Qian X; Li P; Ye L; Xie S
J Pharm Biomed Anal; 2019 Mar; 166():66-70. PubMed ID: 30612075
[TBL] [Abstract][Full Text] [Related]
17. Determination of a astragaloside IV derivative LS-102 in plasma by ultra-performance liquid chromatography-tandem mass spectrometry in dog plasma and its application in a pharmacokinetic study.
Sun WX; Zhang ZF; Xie J; He Y; Cheng Y; Ding LS; Luo P; Qing LS
Phytomedicine; 2019 Feb; 53():243-251. PubMed ID: 30668404
[TBL] [Abstract][Full Text] [Related]
18. UPLC-MS/MS method for the determination of talazoparib in rat plasma and its pharmacokinetic study.
Ye L; Chen J; Li SL; Zhu YL; Xie S; Du X
J Pharm Biomed Anal; 2020 Jan; 177():112850. PubMed ID: 31499430
[TBL] [Abstract][Full Text] [Related]
19. Bioanalysis of lanreotide in dog plasma using liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study of beagle dogs after single subcutaneous injection.
Kim T; Choi S; Lim DS; Yun HY
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123078. PubMed ID: 34891048
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study.
Zhou Y; Li H; He X; Jia M; Ni Y; Xu M; Chen H; Li W
J Pharm Biomed Anal; 2014 Nov; 100():294-299. PubMed ID: 25194342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
